Ensure Your Sterile Compounding Policies Align With USP 797
January 2025
We’re still getting questions about the latest USP <797> standards for sterile compounding.
The latest USP <797> update includes guidance for beyond-use dates, immediate-use preps, and competencies. Help ensure your hospital’s policies are in alignment.
Beyond-use dates (BUDs). Risk groups for sterile compounds are classified as Category 1, 2, or 3...based on where they’re prepared.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote